Doxycycline Hyclate tablets USP — Class II drug recall D-1276-2020
Terminated recall by PD-Rx Pharmaceuticals, Inc., reported 2020-06-03, distributed nationwide. Failed dissolution specifications
| Recall number | D-1276-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK, United States |
| Recall initiated | 2020-05-15 |
| Classified | 2020-05-26 |
| Reported by FDA | 2020-06-03 |
| Terminated | 2021-11-08 |
| Distributed | Nationwide (US) |
| Quantity | 14,030 bottles |
| Reason classes | specification failure |
| NDC | 55289-0866, 55289-0866-01, 55289-0866-02, 55289-0866-04, 55289-0866-06, 55289-0866-07, 55289-0866-10, 55289-0866-14, 55289-0866-20, 55289-0866-28, 55289-0866-30, 55289-0866-50, 55289-0866-60, 55289-0866-71, 55289-0866-74, 55289-0866-82, 55289-0866-85, 55289-0866-86, 55289-0866-87, 55289-0866-90, 55289-0866-93, 55289-0866-95, 55289-0866-98 |
| Expiration dates | 2020-06-30, 2020-08-31, 2020-09-30, 2020-10-31, 2020-11-30, 2020-12-31, 2021-01-31 |
Product
Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC 55289-866-10), c) 14-count (NDC 55289-866-14), d) 20-count (NDC 55289-866-20), e) 28-count (NDC 55289-866-28), f) 30-count (NDC 55289-866-30), g) 60-count (NDC 55289-866-60), h) 120-count (NDC 55289-866-98), i) 210-count (NDC 55289-866-71), j) 300-count (NDC 55289-866-87), k) 400-count (NDC 55289-866-74), Rx only, PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127
Reason for recall
Failed dissolution specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1276-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.